Skip to Content

TEVA 7664 (Erlotinib Hydrochloride 150 mg)

Pill with imprint TEVA 7664 is White, Round and has been identified as Erlotinib Hydrochloride 150 mg. It is supplied by Teva Pharmaceuticals USA, Inc..

Erlotinib is used in the treatment of non-small cell lung cancer; pancreatic cancer and belongs to the drug class EGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Erlotinib 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TEVA 7664

Erlotinib Hydrochloride

Imprint
TEVA 7664
Strength
150 mg
Color
White
Shape
Round
Availability
Prescription only
Drug Class
EGFR inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA, Inc.
National Drug Code (NDC)
00093-7664

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.